Daily Alert – 7/30/19
Nine analysts have increased their earnings estimates for this consulting firm in the last 30 days.
Read More
John Eade is President of Argus Research Company and Senior Analyst. Over the years, John’s responsibilities at Argus have included chairing the Investment Policy Committee as Director of Research, helping form the firm’s overall investment strategy, writing a weekly investment column and authoring the flagship Portfolio Selector. John has also provided coverage of the Healthcare, Financial and Consumer sectors. John has been with Argus since 1989. He has an MBA in Finance from New York University’s Stern School of Business and a Bachelor’s degree in Journalism from Northwestern University’s Medill School of Journalism. He has been interviewed and quoted extensively in The New York Times, Forbes, Time, Fortune and Money magazines, and has been a frequent guest on CNBC, CNN, CBS News, ABC News and the Bloomberg Radio and Television networks. John is a founder and board member of the Investorside Research Association, an industry trade organization. He is also a member of the New York Society of Security Analysts and the CFA Institute.
Nine analysts have increased their earnings estimates for this consulting firm in the last 30 days.
Read More
This energy company beat earnings estimates by $0.09 last quarter, and four analysts have increased their forecasts for the company in the past 30 days.
Read More
This medical device company beat analysts’ EPS estimates by $0.18 last quarter.
Read More
The shares of this global beverage producer were recently upgraded by Goldman Sachs to ‘Buy’.
Read More
The shares of this tech company were also recently initiated at Guggenheim with a ‘Buy’ rating.
Read More
This tech company’s shares were just initiated at Evercore ISI Group, with an ‘Outperform’ rating and upgraded at Deutsche Bank, to ‘Buy’.
Read More
This technology company’s stock was just upgraded by Maxim Group to ‘Buy’.
Read More
The shares of this restaurant company were also just initiated as ‘Outperform’ by Baird.
Read More
Five analysts have raised their EPS estimates for this gaming company. The shares have a current dividend yield of 4.68%, paid quarterly.
Read More
In the past 30 days, 18 analysts have increased their EPS forecasts for this drug maker. The shares have a current dividend yield of 2.77%, paid quarterly.
Read More
This video gaming company continues to lead the sector with innovations to extend game life and increase player engagement.
Read More
This utility has a current dividend yield of 4.18%, paid quarterly. The company will announce quarterly earnings on November 1.
Read More
This utility is a play on growing infrastructure needs. This company has a current dividend yield of 2.47%, paid quarterly.
Read More
This cosmetics company beat analysts’ estimates by $0.08 last quarter and 22 analysts have increased the company’s earnings forecasts for this year.
Read More
This bottling company is rated ‘Strong Buy’ by Zack’s, based on price momentum and rising earnings forecasts. The shares have a current dividend yield of 1.96%, paid quarterly.
Read More
This credit card marketer beat analysts’ estimates by $0.10 in its most recent quarter.
Read More
This technology security company’s EPS estimates for 2017 were just revised upward by 12 analysts.
Check Point Software Technologies Ltd. (CHKP)
From Argus Weekly Staff Report
We are maintaining our BUY rating on Check Point Software Technologies Ltd. (NGS: CHKP) to a target price of $115. see...
Read More
This home builder beat analysts’ earnings estimates by $0.07 last quarter, and its shares were recently upgraded by RBC Capital Mkts to ‘Outperform’.
Read More
Three analysts have raised their 2018 earnings forecast for this animal health company. Wall Street expects double-digit growth for the next five years.
Read More
This tobacco company is forecast to grow by double digits next year. The shares have a current yield of 3.4%, paid quarterly.
Read More